TELIGENE Trademark

Trademark Overview


On Tuesday, June 22, 2021, a trademark application was filed for TELIGENE with the United States Patent and Trademark Office. The USPTO has given the TELIGENE trademark a serial number of 90788862. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Friday, February 23, 2024. This trademark is owned by Suzhou Teligene LTD. The TELIGENE trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of cancer; medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; biochemical medicines, for treating diseases of cardiovascular syst...
teligene

General Information


Serial Number90788862
Word MarkTELIGENE
Filing DateTuesday, June 22, 2021
Status713 - CANCELLED - SECTION 18
Status DateFriday, February 23, 2024
Registration Number7003128
Registration DateTuesday, March 21, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Description of MarkThe mark consists of a design of circle and crescent to the left and stylized word TELIGENE appearing to the right.
Goods and ServicesMedicines for human purposes for the treatment of cancer; medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of immune system and musculo-skeletal system; drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicated ointments for pharmaceutical purposes, namely, antibiotic ointments, antiseptic ointments, anti-itch ointments, anti-viral ointments, medicated sunburn ointments; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; medicines in tablet form for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for medical purposes for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuzhou Teligene LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPARK JIANGSU 215123
CN

Party NameSuzhou Teligene LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPARK JIANGSU 215123
CN

Party NameSuzhou Teligene LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPARK JIANGSU 215123
CN

Trademark Events


Event DateEvent Description
Friday, February 23, 2024CANCELLATION TERMINATED NO. 999999
Friday, February 23, 2024CANCELLED SECTION 18-TOTAL
Thursday, February 22, 2024CANCELLATION GRANTED NO. 999999
Tuesday, November 21, 2023CANCELLATION INSTITUTED NO. 999999
Tuesday, March 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 17, 20221(B) BASIS DELETED; NEW BASIS REQUESTED
Thursday, November 17, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, November 17, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, November 16, 2022ASSIGNED TO PETITION STAFF
Thursday, November 3, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 29, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 29, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, March 29, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, March 12, 2022ASSIGNED TO EXAMINER
Wednesday, September 8, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 25, 2021NEW APPLICATION ENTERED